Milestone Pharmaceuticals Inc. financial data

Symbol
MIST on Nasdaq
Location
1111 Boul. Dr. Frederik Philips, Ste 420, Montreal, Quebec, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 734 % -48%
Debt-to-equity 1.91K % +873%
Return On Equity -1.67K % -911%
Return On Assets -83 % -49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85M shares +59.6%
Common Stock, Shares, Outstanding 53.5M shares +0.42%
Common Stock, Value, Issued 288M USD +0.12%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.6M USD -11.2%
General and Administrative Expense 16.7M USD +0.43%
Operating Income (Loss) -55M USD -11.6%
Net Income (Loss) Attributable to Parent -55.5M USD -14.7%
Earnings Per Share, Basic 0 USD/shares +18.6%
Earnings Per Share, Diluted 0 USD/shares +18.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.5M USD +220%
Cash, Cash Equivalents, and Short-term Investments 43.4M USD -47.9%
Assets, Current 46.2M USD -47.2%
Property, Plant and Equipment, Net 159K USD -28.4%
Operating Lease, Right-of-Use Asset 1.09M USD -34%
Assets 47.4M USD -46.9%
Employee-related Liabilities, Current 2.03M USD +43.5%
Liabilities, Current 9.28M USD +103%
Operating Lease, Liability, Noncurrent 641K USD -44.6%
Liabilities 65.2M USD +13.8%
Retained Earnings (Accumulated Deficit) -401M USD -16.1%
Stockholders' Equity Attributable to Parent -17.7M USD -155%
Liabilities and Equity 47.4M USD -46.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14M USD -56.2%
Net Cash Provided by (Used in) Financing Activities 140K USD -99.6%
Net Cash Provided by (Used in) Investing Activities 33.6M USD
Common Stock, Shares, Issued 53.5M shares +0.42%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 19.8M USD
Deferred Tax Assets, Valuation Allowance 89.4M USD +11.4%
Deferred Tax Assets, Gross 89.4M USD +11.4%
Operating Lease, Liability 1.45M USD -27.9%
Payments to Acquire Property, Plant, and Equipment 6K USD
Lessee, Operating Lease, Liability, to be Paid 1.59M USD -30.1%
Property, Plant and Equipment, Gross 488K USD +4.27%
Operating Lease, Liability, Current 515K USD -9.17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 530K USD -20.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 658K USD -2.23%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 149K USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three 406K USD -23.4%
Deferred Tax Assets, Operating Loss Carryforwards 72.8M USD +9.18%
Additional Paid in Capital 42.2M USD +14.9%
Depreciation, Depletion and Amortization 27K USD -3.57%
Share-based Payment Arrangement, Expense 5.53M USD -27.7%